Annual EPS
$1.59$1.39-46.69%
Summary
- Current Value
- As of today, GSK annual EPS is $1.59, down -46.69% on
- Historical Performance
- GSK annual EPS is down -57.30% over the past 3 years, and down -46.21% over the past 5 years
- All-Time High Comparison
- GSK annual EPS is currently -82.39% below its historical high of $9.02 set on
- 3-Year Low Comparison
- GSK annual EPS is at its 3-year low
- Sector Comparison
- GSK annual EPS is higher than 90.54% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate GSK annual EPS at $4.50, +183.38% higher than the current value
- Upcoming Earnings
- The next annual earnings release for GSK is on
EPS Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EPS | $1.59 | -46.7% | -57.3% | -46.2% | -62.6% | |
| Quarterly EPS | $1.32 | +3676.5% | -78.7% | +66.0% | +35.2% | |
| TTM EPS | $3.51 | +128.1% | -59.0% | -12.9% | +14.3% | |
| Price | $48.22 | +44.2% | +36.3% | +22.9% | +20.7% | |
| Annual Revenue | $40.09B | +6.3% | +18.0% | -6.9% | -9.9% | |
| PE Ratio | 13.75 | -34.9% | +241.2% | +27.4% | -57.3% | |
| Annual Net Income | $3.77B | -42.9% | -22.0% | -43.9% | -57.6% | |
| Annual Gross Profit | $27.98B | +5.9% | +24.5% | -4.2% | -15.9% | |
| Shares Outstanding | 2.01B | -1.5% | -1.8% | -0.1% | – |
EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.02 | N/A | -82.4% |
| 5Y | $9.02 | -82.4% | |
| All | $9.02 | -82.4% |
EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.59 | at low | |
| 5Y | $1.59 | at low | |
| All | $0.63 | +153.9% |
EPS Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.97 | $2.98 | -24.93% | |
| $3.92 | $1.59 | -59.44% | |
| $4.50 | N/A | +183.38% | |
| $4.82 | N/A | +203.26% |
🔒 Log In To Unlock Full Data
EPS History
FAQ
What is the current annual EPS of GSK?
As of today, GSK annual EPS is $1.59
What is 1-year change in GSK annual EPS?
GSK annual EPS is down -46.69% year-over-year
What is 3-year change in GSK annual EPS?
GSK annual EPS is down -57.30% over the past 3 years
How far is GSK annual EPS from its all-time high?
GSK annual EPS is currently -82.39% below its historical high of $9.02 set on December 31, 2022
How does GSK annual EPS rank versus sector peers?
GSK annual EPS is higher than 90.54% of companies in Healthcare sector
How does the analyst estimate for GSK annual EPS compare to its current value?
Analysts estimate GSK annual EPS at $4.50, +183.38% higher than the current value
When is GSK next annual earnings release?
The next annual earnings release for GSK is on
Quarterly EPS
$1.32$0.39+41.09%
Summary
- Current Value
- As of today, GSK quarterly EPS is $1.32, up +41.09% on
- Historical Performance
- GSK quarterly EPS is up +3676.49% year-over-year, and down -78.74% over the past 3 years
- All-Time High Comparison
- GSK quarterly EPS is currently -78.94% below its historical high of $6.28 set on
- 3-Year Low Comparison
- GSK quarterly EPS is +3676.49% above its 3-year low of -$0.04 reached on
- Sector Comparison
- GSK quarterly EPS is higher than 94.36% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate GSK quarterly EPS at $0.62, -52.85% lower than the current value
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EPS | $1.32 | +41.1% | +3676.5% | -78.7% | +66.0% | |
| Annual EPS | $1.59 | – | -46.7% | -57.3% | -46.2% | |
| TTM EPS | $3.51 | +63.4% | +128.1% | -59.0% | -12.9% | |
| Price | $48.22 | +10.2% | +44.2% | +36.3% | +22.9% | |
| Quarterly Revenue | $11.52B | +8.0% | +10.6% | +25.2% | +3.2% | |
| PE Ratio | 13.75 | +10.2% | -34.9% | +241.2% | +27.4% | |
| Quarterly Net Income | $2.89B | +31.5% | +3321.0% | +215.7% | +56.5% | |
| Quarterly Gross Profit | $8.51B | +9.4% | +15.1% | +33.5% | +11.2% | |
| Shares Outstanding | 2.01B | – | -1.5% | -1.8% | -0.1% |
Quarterly EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.32 | at high | |
| 3Y | $1.32 | at high | |
| 5Y | $6.22 | -78.7% | |
| All | $6.28 | -78.9% |
Quarterly EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.26 | N/A | +416.3% |
| 3Y | -$0.04 | +3676.5% | |
| 5Y | -$0.04 | +3676.5% | |
| All | -$0.53 | +351.0% |
Quarterly EPS Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.11 | $0.94 | -15.52% | |
| $1.26 | $1.32 | +4.84% | |
| $0.62 | N/A | -52.85% | |
| $1.21 | N/A | -8.70% |
🔒 Log In To Unlock Full Data
Quarterly EPS History
FAQ
What is the current quarterly EPS of GSK?
As of today, GSK quarterly EPS is $1.32
What is GSK quarterly EPS most recent change?
GSK quarterly EPS was up +41.09% on September 1, 2025
What is 1-year change in GSK quarterly EPS?
GSK quarterly EPS is up +3676.49% year-over-year
How far is GSK quarterly EPS from its all-time high?
GSK quarterly EPS is currently -78.94% below its historical high of $6.28 set on March 31, 2015
How does GSK quarterly EPS rank versus sector peers?
GSK quarterly EPS is higher than 94.36% of companies in Healthcare sector
How does the analyst estimate for GSK quarterly EPS compare to its current value?
Analysts estimate GSK quarterly EPS at $0.62, -52.85% lower than the current value
When is GSK next earnings release?
The next earnings release for GSK is on
TTM EPS
$3.51$1.36+63.39%
Summary
- Current Value
- As of today, GSK TTM EPS is $3.51, up +63.39% on
- Historical Performance
- GSK TTM EPS is up +128.13% year-over-year, and down -59.00% over the past 3 years
- All-Time High Comparison
- GSK TTM EPS is currently -60.87% below its historical high of $8.96 set on
- 3-Year Low Comparison
- GSK TTM EPS is +128.13% above its 3-year low of $1.54 reached on
- Sector Comparison
- GSK TTM EPS is higher than 93.73% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate GSK TTM EPS at $3.87, +10.49% higher than the current value
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EPS | $3.51 | +63.4% | +128.1% | -59.0% | -12.9% | |
| Quarterly EPS | $1.32 | +41.1% | +3676.5% | -78.7% | +66.0% | |
| Annual EPS | $1.59 | – | -46.7% | -57.3% | -46.2% | |
| Price | $48.22 | +10.2% | +44.2% | +36.3% | +22.9% | |
| TTM Revenue | $42.06B | +2.7% | +6.0% | +13.4% | -3.7% | |
| PE Ratio | 13.75 | +10.2% | -34.9% | +241.2% | +27.4% | |
| TTM Net Income | $7.96B | +54.4% | +121.5% | +66.2% | -11.3% | |
| TTM Gross Profit | $30.47B | +3.8% | +8.7% | +25.9% | +4.1% | |
| Shares Outstanding | 2.01B | – | -1.5% | -1.8% | -0.1% |
TTM EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.51 | at high | |
| 3Y | $8.96 | -60.9% | |
| 5Y | $8.96 | -60.9% | |
| All | $8.96 | -60.9% |
TTM EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.58 | N/A | +121.6% |
| 3Y | $1.54 | +128.1% | |
| 5Y | $1.54 | +128.1% | |
| All | $0.00 | N/A |
TTM EPS History
FAQ
What is the current TTM EPS of GSK?
As of today, GSK TTM EPS is $3.51
What is GSK TTM EPS most recent change?
GSK TTM EPS was up +63.39% on September 1, 2025
What is 1-year change in GSK TTM EPS?
GSK TTM EPS is up +128.13% year-over-year
How far is GSK TTM EPS from its all-time high?
GSK TTM EPS is currently -60.87% below its historical high of $8.96 set on June 30, 2023
How does GSK TTM EPS rank versus sector peers?
GSK TTM EPS is higher than 93.73% of companies in Healthcare sector
How does the analyst estimate for GSK TTM EPS compare to its current value?
Analysts estimate GSK TTM EPS at $3.87, +10.49% higher than the current value
When is GSK next earnings release?
The next earnings release for GSK is on
EPS Formula
EPS =
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1131399/000113139925000007/0001131399-25-000007-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk